@ArthurPeyrottes Profile picture

Peyrottes Arthur

@ArthurPeyrottes

Urology resident 💦 | @AFUFuro member | CCAFU-prostate junior associate 🌰🎗| @HopSaintLouis 🇫🇷 | Rugby addict 🏉

Similar User
UroCCR photo

@uroccr

gilles karsenty photo

@gilkarsenty

Pignot Géraldine photo

@PignotG

Charles Dariane photo

@CharlesDariane

Lucas Freton photo

@LFreton

Bigot Pierre photo

@BigotP

Florian Bardet photo

@bardet_florian

Jb Beauval photo

@jbbeauval

Julien Anract photo

@AnractJulien

Kevin Kaulanjan photo

@KevinKaulanjan

MathieuRoumiguié photo

@MRoumiguie

CFEUrologie photo

@CfeUrologie

Romain Boissier photo

@R_Boissier

Denis Séguier photo

@denis_seguier

Cécile CHAMPY photo

@CecileChampy

Le programme qui fera avancer votre projet grâce à l’@AFUrologie! Internes et chefs, saisissez votre chance! 🍀 @afufuro @fayek_taha @AnnaGoujon @denis_seguier @GaelleMargue @S_Levy_Urologue @pldequirez

Graines et Sol 2024, le séminaire pour faire germer ses idées 💡 🚨 Ne ratez pas l'appel à projet que nous diffuserons sur nos réseaux sociaux entre novembre et décembre. @afufuro



Peyrottes Arthur Reposted

Merci à @AFUrologie pour cette nouvelle campagne de sensibilisation et d'information contre les cancers masculins (cancer de prostate, cancer des testicules...). Nous restons attentifs #Movember

Tweet Image 1

Peyrottes Arthur Reposted

La formation radioprotection est obligatoire pour tous en urologie : internes DJ CCA et plus ! L’@AFUrologie organise des formations du volet « patient » pour l’année à venir ! forms.gle/ywmWRzPSx7jy4a… @afufuro @fayek_taha @ArthurPeyrottes @delataillealex


Peyrottes Arthur Reposted

🚨30-year follow-up prostatectomy vs observation for #ProstateCancer 🚨 ✅New results from SPCG-4 😀695 patients enrolled 1989-1999 👉88% ≥T2 disease 🩹Surgery resulted in 2.2 life years gained 🔗shorturl.at/VXAgp @PCFnews @PCF_Science #PCSM @UrologyTimes @urotoday

Tweet Image 1
Tweet Image 2

Peyrottes Arthur Reposted

🚨Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer🚨 👏Landmark trial in urology in @NEJM 😷592 patients randomized 🗓️Median f/u 6.1 years 👉No difference in... 5-year disease-free survival (60% v 56%) 5-year overall survival (63% v 59%)…

Tweet Image 1
Tweet Image 2

Peyrottes Arthur Reposted

🚨4-year follow-up of the Gothenburg MRI-targeted only vs systematic biopsy for 🚨 @NEJM >13k patients studied Biopsies of only MRI lesions leads to... 📉<Half as many biopsies (588➡️254) 📉<Half as many diagnoses of GG1 PCa (159➡️68) ⚖️No difference in ≥GG2 PCa (139 vs 117)…

Tweet Image 1
Tweet Image 2

Peyrottes Arthur Reposted

Molecular subtypes and outcomes in the #VESPER trial. Presentation by Yves Allory @institut_curie #IBCN2024 written coverage by @zklaassen_md @GACancerCenter > bit.ly/3XBQt5a @IBCN1997 #IBCN24

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

AI models do not outperform standard models in predicting BCR in Afro-Caribbean descendant @KevinKaulanjan

Tweet Image 1

L’@AFUrologie et l’@afufuro bien représentées au congrès Prostate Cancer 2050: Back to the Future à Rotterdam 🤖 @CharlesDariane @KevinKaulanjan @JennKa12 @AleClerget and Pr P. Mongiat-Artus @Urology2050 ➡️future is great!! 🤩

Tweet Image 1

Micro-US biopsy will replace MRI? Nice talk from @CharlesDariane challenging the current standard of care! And all of this, in a church!!!! ⛪️ #PCa2050

Tweet Image 1

Peyrottes Arthur Reposted

💡Poster presentation & price winning ideas!🏆 Present your groundbreaking sustainability ideas at our Poster Presentation event, Friday, September 20th. Win a prize of 500 euros for the best poster selected by junior faculty🌍💡#Sustainability #Innovation #ProstateCancer2050🌍


Peyrottes Arthur Reposted

On vous attend nombreux ! Le lien est d'inscription est ici : colloquium.idloom.events/les-rencontres… Le pré-programme est à suivre bientôt.

Les Rencontres se dérouleront à Lille du 20 au 22 septembre 2024. Venez assister au programme riche de ces journées, allez à la rencontre des sponsors présents, découvrez les nouveautés de l'urologie et, partagez un moment convivial aux côtés des internes et CCA.

Tweet Image 1


Peyrottes Arthur Reposted

Does blinding matter in trials of procedural interventions and surgery? This meta-analysis identifies how the placebo effect influences clinical trial results. Placebo-control is essential for exercise, quality of life and physician assessed endpoints. ja.ma/4d6928z

Tweet Image 1

Peyrottes Arthur Reposted

Prof. dr. Bangma announces the #prostatecancer2050 congress during the EAU. This congress will take place in Rotterdam, September 2024. Interested? Register now: scem.nl/evenement/2871… #EAU #Rotterdam

Tweet Image 1

Peyrottes Arthur Reposted

🔍✨ New #ProstateCancer study unveils updated #PRECISE recommendations for MRI in active surveillance. Key findings: ✅ Standardized image quality is vital 🖥️Comparison with baseline and previous scans essential 📈Clarifications on lesion measurement and progression criteria…

Tweet Image 1

Thanks a lot @AFUrologie and all for the opportunity! 🙏🏻 Looking forward the future collaborations!! ✍🏻 @GaelleFiard @CharlesDariane @GPloussard @delataillealex @afufuro

Proud to see the results of our AS cohort for men with PIRADS 5 lesions brilliantly presented by @ArthurPeyrottes at #EAU24 - thanks to all collaborators! 🤝@AFUrologie @afufuro

Tweet Image 1


Go @afufuro, go! 🔥

Strong team of French young urologists at #EAU24 @afufuro @Uroweb @AFUrologie

Tweet Image 1


Peyrottes Arthur Reposted

Does the use of sterile gloves vs nonsterile clean gloves for the repair of wounds & lacerations make a difference in SSIs? This systematic review & meta-analysis found no difference. ja.ma/48h0IPp @LoaiAlbarqouni


Peyrottes Arthur Reposted

Our latest on ctDNA% in mCRPC in @NatureComms: we affirm the independent strong prognostic implications & present a tool for predicting pre-blood draw whether ctDNA% is sufficiently high for genomic biomarker testing (e.g. BRCA2). Thread 👇. 1/n nature.com/articles/s4146…

Tweet Image 1
Tweet Image 2

Peyrottes Arthur Reposted

Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsies: Results of PERFECT trial (CCAFU-PR1) ⁦@MRoupret⁩ ⁦@barret_e⁩ ⁦@GaelleFiard⁩ ⁦@jbbeauval⁩ ⁦@AmbroiseSalin⁩ ⁦@EurUrolOncol⁩ ⁦@AFUrologiesciencedirect.com/science/articl…


Loading...

Something went wrong.


Something went wrong.